Literature DB >> 8273581

Effect of 5-lipoxygenase inhibitors on in situ LTB4 biosynthesis following calcium ionophore stimulation in the rat pleural cavity.

A Raychaudhuri1, H Chertock, J Peppard, W D White, J Koeler, G DiPasquale.   

Abstract

The intrapleural injection of carrageenan in the rat induces exudate formation, cellular influx and leukotriene generation in the pleural cavity. We have demonstrated that the inflammatory response (exudate volume, and LTB4 levels) is increased in situ by the intrapleural administration of calcium ionophore A 23187 (100 nmol/rat) at 4, 16, 24, 48, and 72 h after the injection of carrageenan and that the A 23187-induced increase is dose-dependent. The oral administration of A-64077 and MK-886, two 5-lipoxygenase inhibitors (5-LOIs), at 10 mg/kg causes marked decreases in LTB4 release at the above-mentioned time intervals. However, A 23187-induced augmented exudate formation is not affected by the treatment with 5-LOIs. The results suggest that the use of 5-LOIs to inhibit LTB4 biosynthesis may be beneficial in various LTB4-dependent pathological conditions.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8273581     DOI: 10.1007/bf01972715

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  7 in total

1.  Inhibition of leukotriene B4 biosynthesis by disulfiram and A-64077 during carrageenan-induced pleurisy in the rat.

Authors:  D Riendeau; J Guay; A Foster; S Wolfe; C C Chan
Journal:  Gen Pharmacol       Date:  1991

2.  Effect of capsaicin on carrageenan-induced inflammation in rat pleurisy and exudate substance P level.

Authors:  A Raychaudhuri; C Colombo; G Pastor; M Wong; A Y Jeng
Journal:  Agents Actions       Date:  1991-09

Review 3.  Formation and actions of leukotrienes.

Authors:  P J Piper
Journal:  Physiol Rev       Date:  1984-04       Impact factor: 37.312

Review 4.  Leukotrienes: their formation and role as inflammatory mediators.

Authors:  A W Ford-Hutchinson
Journal:  Fed Proc       Date:  1985-01

5.  L-663,536 (MK-886) (3-[1-(4-chlorobenzyl)-3-t-butyl-thio-5-isopropylindol-2-yl]-2,2 - dimethylpropanoic acid), a novel, orally active leukotriene biosynthesis inhibitor.

Authors:  J Gillard; A W Ford-Hutchinson; C Chan; S Charleson; D Denis; A Foster; R Fortin; S Leger; C S McFarlane; H Morton
Journal:  Can J Physiol Pharmacol       Date:  1989-05       Impact factor: 2.273

6.  Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes.

Authors:  A W Ford-Hutchinson; M A Bray; M V Doig; M E Shipley; M J Smith
Journal:  Nature       Date:  1980-07-17       Impact factor: 49.962

7.  Leukotrienes: mediators of immediate hypersensitivity reactions and inflammation.

Authors:  B Samuelsson
Journal:  Science       Date:  1983-05-06       Impact factor: 47.728

  7 in total
  1 in total

1.  Inhibition of leukotriene synthesis with MK-886 prevents a rise in blood pressure and reduces noradrenaline-evoked contraction in L-NAME-treated rats.

Authors:  Françoise Stanke-Labesque; Gaëlle Hardy; Françoise Caron; Jean-Luc Cracowski; Germain Bessard
Journal:  Br J Pharmacol       Date:  2003-07-29       Impact factor: 8.739

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.